In summary, we failed to identify anti-KIR4.1 antibodies in patients with MS using the full-length, low-glycosylated KIR4.1 ELISA assay and HEK293 and oligodendrocyte cell-based assays. The gene discussed is KCNJ10; the disease is myeloid sarcoma.